The effect of clonidine on the cessation of cigarette smoking

The effect of clonidine on smoking cessation was studied by randomly assigning 186 smokers in a double-blind fashion to either placebo or clonidine. Abstinence from smoking was reported more frequently by subjects receiving clonidine, but the difference was statistically significant only at the end of the first week (34.4% vs 21.5%; p < 0.05). Bothersome side effects were common and resulted in the early discontinuation of the study medication by 23 of the subjects taking clonidine and eight taking placebo (p < 0.05). Although this study did not demonstrate a significant effects of clonidine on smoking cessation, a beneficial trend was detected and therefore fiwther trials with transcutaneous delivery of this agent in combination with behavior modification techniques are warranted.